Holen Sie sich die Stockscreener-App
12.17
0.65%
-0.08
Intellia Therapeutics Inc Aktie (NTLA) Neueste Nachrichten
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure ... - The Bakersfield Californian
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA - GlobeNewswire Inc.
Intellia signs major lease for expansion, amends existing lease By Investing.com - Investing.com Nigeria
Intellia signs major lease for expansion, amends existing lease - Investing.com India
Intellia Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
NTLA Investors are Suing Intellia Therapeutics, Inc.; Contact Robbins LLP for More Information - GlobeNewswire
Faruqi & Faruqi Reminds Intellia Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025NTLA - PR Newswire
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar? - Nasdaq
Intellia Therapeutics to Hold Conference Call to Discuss - GlobeNewswire
Gene Editing Pioneer Intellia Sets Critical Q4 Earnings Review: Will CRISPR Progress Match Expectations? - StockTitan
The Gross Law Firm Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Intellia Therapeutics (NTLA) Expected to Announce Earnings on Thursday - MarketBeat
NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - GlobeNewswire
Chevy Chase Trust Holdings LLC Sells 522,712 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming DeadlinesNTLA - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - TradingView
Shareholders of Intellia Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders of Intellia Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLA - TradingView
How to Take Advantage of moves in (NTLA) - Stock Traders Daily
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Intellia - GlobeNewswire
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA) DEADLINE ALERT: - GlobeNewswire
Intellia Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - Morningstar
NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
2025-02-16 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics | NDAQ:NTLA | Press Release - Stockhouse Publishing
Sumitomo Mitsui Trust Group Inc. Sells 156,736 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) - MarketBeat
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages - GlobeNewswire
Intellia Therapeutics (NASDAQ:NTLA) Sets New 1-Year LowWhat's Next? - MarketBeat
INTELLIA ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Intellia Therapeutics (NTLA): Among The Small–Cap Stocks Insiders Are Selling Recently - Insider Monkey
Does Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect? - Yahoo Finance
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc.(NTLA) Shareholders - PR Newswire
Intellia Therapeutics (NASDAQ:NTLA) Sets New 12-Month LowShould You Sell? - MarketBeat
Intellia Therapeutics, Inc. Shareholder Notice: Shareholder - GlobeNewswire
Intellia Therapeutics, Inc. Shareholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against NTLA - GlobeNewswire
Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Bakersfield Californian
Investor Alert: Robbins LLP Informs Stockholders of the Intellia Therapeutics, Inc. Class Action - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA) INVESTOR ALERT: - GlobeNewswire
INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA) INVESTOR ALERT: Investors With Large Losses in - The Bakersfield Californian
NTLA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):